Mark Taylor

Mark Taylor is an experienced professional in technology development and commercialization, currently serving as Director of Commercialization at University Health Network since February 2008. Mark has held various leadership roles within the organization, including Interim Director and Associate Director. In addition to these positions, Mark is involved as a Board Observer for Adela, Inc. and Treadwell Therapeutics, Inc. Previously, Mark served as Chair of the Board of Directors for Acumyn Inc. during its acquisition by Elekta Ltd., and as a Board Observer for AVROBIO, culminating in a successful NASDAQ IPO. Mark holds a Master of Science in Engineering Mechanics from Virginia Polytechnic Institute and State University, a Bachelor of Applied Science in Engineering Science from the University of Toronto, and an MBA from the University of Toronto - Rotman School of Management.